DarioHealth (NASDAQ:DRIO) Share Price Crosses Below 200-Day Moving Average – Here’s What Happened

DarioHealth Corp. (NASDAQ:DRIO) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.82 and traded as low as $0.64. DarioHealth shares last traded at $0.67, with a volume of 98,366 shares traded.

Wall Street Analyst Weigh In

Separately, TD Cowen cut DarioHealth from a “buy” rating to a “hold” rating and decreased their price target for the stock from $2.00 to $1.00 in a research report on Wednesday, January 29th.

DarioHealth Stock Up 3.3 %

The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32. The company has a market cap of $22.90 million, a P/E ratio of -0.71 and a beta of 1.39. The stock has a 50-day moving average of $0.73 and a 200 day moving average of $0.82.

Institutional Trading of DarioHealth

Several large investors have recently bought and sold shares of the business. DLK Investment Management LLC boosted its stake in DarioHealth by 40.9% in the fourth quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock valued at $111,000 after buying an additional 41,107 shares in the last quarter. XTX Topco Ltd boosted its stake in DarioHealth by 81.4% in the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock valued at $33,000 after buying an additional 13,219 shares in the last quarter. Finally, Appian Way Asset Management LP boosted its stake in DarioHealth by 2.5% in the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock valued at $1,580,000 after buying an additional 34,990 shares in the last quarter. 33.39% of the stock is owned by institutional investors and hedge funds.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.